J&J Ups Sales Forecast as Cancer Drugs Drive Growth

(Bloomberg) -- Johnson & Johnson raised its revenue guidance for the year, as strong sales in its pharmaceutical unit helped cushion a decline in the consumer and medical technology businesses.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.